The etiology and prevention of breast cancer

Drug Discovery Today: Disease Mechanisms

Volumn 9, Issue 1-2, 2012, Pages

  Cavalieri, Ercole L ^a   Rogan, Eleanor G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; QUINONE DERIVATIVE; RESVERATROL;

BREAST CANCER; CANCER PREVENTION; CARCINOGENICITY; DNA ADDUCT; DRUG MECHANISM; GENE MUTATION; HOMEOSTASIS; REVIEW;

EID: 84875209721     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2013.02.001     Document Type: Review

References (119)

1. E.C. Miller, and J.A. Miller Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules Pharmacol. Rev. 18 1966 805 838
2. J.A. Miller Carcinogenesis by chemicals: an overview-G.H.A. Clowes Memorial Lecture Cancer Res. 30 1970 559 576
3. E.C. Miller, and J.A. Miller Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules Cancer 47 1981 2327 2345
4. C. Shih Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin Proc. Natl. Acad. Sci. U.S.A. 76 1979 5714
5. E.L. Cavalieri, and E.G. Rogan The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation Pharmacol. Ther. 55 1992 183 199
6. E.L. Cavalieri, and E.G. Rogan Mechanisms of tumor initiation by polycyclic aromatic hydrocarbons in mammals A.H. Neilson, The Handbook of Environmental Chemistry 1998 Springer-Verlag 81 117
7. E.L. Cavalieri, and E.G. Rogan Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers Future Oncol. 6 2010 75 91
8. E. Cavalieri, and E. Rogan Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer J. Steroid Biochem. Mol. Biol. 125 2011 169 180
9. A. Pullman, and B. Pullman Molecular electrostatic potential of the nucleic acids Q. Rev. Biophys. 14 1981 289 380
10. D. Chakravarti Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites Proc. Natl. Acad. Sci. U.S.A. 92 1995 10422 10426
11. D. Chakravarti Detection of dibenzo[a,l]pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method Oncogene 16 1998 3203 3210
12. D. Chakravarti Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia Mutat. Res. 456 2000 17 32
13. E.L. Cavalieri Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases Carcinogenesis 23 2002 1071 1077
14. M. Zahid Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease Free Radic. Biol. Med. 48 2010 318 324
15. M. Saeed Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene Chem. Biol. Interact. 165 2007 175 188
16. M. Saeed Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation Free Radic. Biol. Med. 47 2009 1075 1081
17. D. Stack Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides Chem. Res. Toxicol. 9 1996 851 859
18. E.L. Cavalieri Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators Proc. Natl. Acad. Sci. U.S.A. 94 1997 10937 10942
19. K-M. Li Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo Carcinogenesis 25 2004 289 297
20. M. Saeed Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3′,4′-quinone. Implications for mutagenic activity Steroids 70 2005 29 35
21. M. Zahid The greater reactivity of estradiol-3,4-quinone versus estradiol-2,3-quinone with DNA in the formation of depurinating adducts, Implications for tumor-initiating activity Chem. Res. Toxicol. 19 2006 164 172
22. M. Saeed Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens Int. J. Cancer 124 2009 1276 1284
23. S-T. Jan Metabolic activation and formation of DNA adducts of hexestrol, a synthetic non-steroidal carcinogenic estrogen Chem. Res. Toxicol. 11 1998 412 419
24. M. Saeed Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3′-4′-quinone or enzyme-activated 3′-hydroxyhexestrol, Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens Steroids 70 2005 37 45
25. E.L. Cavalieri, and E.G. Rogan Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol? IUBMB Life 62 2010 746 751
26. Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J. Natl. Cancer Inst. 94 2002 606 616
27. R. Kaaks Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) J. Natl. Cancer Inst. 97 2005 755 765
28. S. Nandi Role of hormones in mammary neoplasia Cancer Res. 38 1978 4046 4049
29. J.J. Li Estrogen carcinogenesis in hamster tissues: update Endocr. Rev. 14 1993 94 95
30. R. Lang, and U. Redmann Non-mutagenicity of some sex hormones in the Ames salmonella/microsome mutagenicity test Mutat. Res. 67 1979 361 365
31. R. Lang, and R. Reimann Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: examination for the induction of gene mutations using the Ames Salmonella/microsome test and the HGPRT test in V79 cells Environ. Mol. Mutagen. 21 1993 272 304
32. C. Drevon Mutagenicity assays of estrogenic hormones in mammalian cells Mutat. Res. 89 1981 83 90
33. H.S. Feigelson, and B.E. Henderson Estrogens and breast cancer Carcinogenesis 17 1996 2279 2284
34. R.B. Dickson, and G.M. Stancel Estrogen receptor-mediated processes in normal and cancer cells J. Natl. Cancer Inst. Monogr. 27 2000 135 145
35. J. Furth Hormones as etiological agents in neoplasia F.F. Becker, Cancer. A Comprehensive Treatise. 1. Etiology: Chemical and Physical Carcinogenesis 1982 Cancer Plenum Press 89 134 (Chapter 4)
36. J.J. Li, and S.A. Li Estrogen carcinogenesis in hamster tissues: a critical review Endocr. Rev. 11 1990 524 531
37. S. Nandi Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis Proc. Natl. Acad. Sci. U.S.A. 92 1995 3650 3657
38. W.C. Hahn, and R.A. Weinberg Rules for making human tumor cells N. Engl. J. Med. 347 2002 1593 1603
39. E. Cavalieri Estrogens as endogenous genotoxic agents: DNA adducts and mutations E. Cavalieri, E. Rogan, JNCI Monograph: Estrogens as Endogenous Carcinogens in the Breast and Prostate, No. 27 2000 Oxford University Press 75 93
40. E. Cavalieri Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention Biochim. Biophys. Acta 1766 2006 63 78
41. B.T. Zhu, and A.H. Conney Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 9 1998 1 27
42. D.C. Spink The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in mcf-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase J. Steroid Biochem. Mol. Biol. 51 1994 251 258
43. C.L. Hayes 17β-Estradiol hydroxylation catalyzed by human cytochrome p450 1b1 Proc. Natl. Acad. Sci. U.S.A. 93 1996 9776 9781
44. D.C. Spink Differential expression of CYP1a1 and CYP1b1 in human breast epithelial cells and breast tumor cells Carcinogenesis 19 1998 291 298
45. P.T. Männistö, and S. Kaakkola Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol. Rev. 51 1999 593 628
46. Yager, J. (2012) Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer. Drug Discov. Today: Dis. Mech. http://dx.doi.org/10.1016/j.ddmec.2012.10.002
47. H. Kappus Lipid peroxidation: mechanisms, analysis, enzymology and biological relevance H. Sies, Oxidative Stress 1985 Academic Press 273 310
48. J.G. Liehr Carcinogenicity of catechol estrogens in Syrian hamsters J. Steroid Biochem. 24 1986 353 356
49. J.J. Li, and S.A. Li Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism Fed. Proc. 46 1987 1858 1863
50. R.R. Newbold, and J.G. Liehr Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens Cancer Res. 60 2000 235 237
51. J.A. Mobley Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro Chem. Toxicol. 12 1999 270 277
52. E. Cavalieri Minisymposium on endogenous carcinogens: the catechol estrogen pathway. An introduction Polycyclic Aromat. Compd. 6 1994 223 228
53. D.E. Stack Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones Chem. Res. Toxicol. 21 2008 1415 1425
54. J.L. Bolton, and L. Shen p-Quinone methides are the major decomposition products of catechol estrogen o-quinones Carcinogenesis 17 1998 925 929
55. N.W. Gaikwad Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones Free Radic. Biol. Med. 43 2007 1289 1298
56. N.W. Gaikwad Evidence from ESI-MS for NQO2-catalyzed reduction of estrogen ortho-quinones Free Radic. Biol. Med. 46 2009 253 262
57. P. Talalay Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis Adv. Enzyme Regul. 43 2003 121 134
58. E. Cavalieri Mechanism of DNA depurination by carcinogens in relation to cancer initiation IUBMB Life 64 2012 169 179
59. P.D. Devanesan Identification and quantitation of 7,12-dimethylbenz[a] anthracene-DNA adducts formed in mouse skin Chem. Res. Toxicol. 6 1993 364 371
60. E.L. Cavalieri Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P), or its metabolites and in rat mammary gland treated with DB[a,l]P Chem. Res. Toxicol. 18 2005 976 983
61. R. Todorovic Identification and quantification of stable DNA adducts of dibenzo[a,l]pyrene or its metabolites in vitro, and in mouse skin and rat mammary gland Chem. Res. Toxicol. 18 2005 984 990
62. E.G. Rogan Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin Chem. Res. Toxicol. 6 1993 356 363
63. D. Chakravarti Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and form mutations in the H-ras gene Oncogene 20 2001 7945 7953
64. P.C. Mailander Induction of A.T. to G.C. mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats J. Steroid Biochem. Mol. Biol. 101 2006 204 215
65. A-M. Colapietro Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels Carcinogenesis 14 1993 2289 2295
66. J.G. Liehr Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21 2000 40 54
67. World Health Organization IARC TP53 Database 2012 http://www.carc.fr/p53/ index.html
68. S.V. Fernandez Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells Int. J. Cancer 118 2006 1862 1868
69. M.S. Greenblatt TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution Cancer Res. 61 2001 4092 4097
70. Z. Zhao Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB2 rat embryonic cells, and the mutational spectrum of 4-hydroxyestradiol Chem. Res. Toxicol. 19 2006 475 479
71. S. Dawling Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1 Cancer Res. 3 2003 3127 3132
72. W.R. Miller, and J. O'Neill The importance of local synthesis of estrogen within the breast Steroids 50 1987 537 548
73. E.R. Simpson Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr. Rev. 15 1994 342 355
74. C.R. Jefcoate Tissue-specific synthesis and oxidative metabolism of estrogens E. Cavalieri, E. Rogan, JNCI Monograph 27: Estrogens as Endogenous Carcinogens in the Breast and Prostate 2000 Oxford Press 95 112
75. S.J. Santner In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway J. Clin. Endocrinol. Metab. 59 1984 29 33
76. J.R. Pasqualini Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients J. Clin. Endocrinol. Metab. 81 1996 1460 1464
77. F. Lu Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p- dioxin induction and catechol-O-methyltransferase inhibition J. Steroid Biochem. Mol. Biol. 105 2007 150 158
78. F. Lu Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells Cancer Prev. Res. 1 2008 135 145
79. K. Mitrunen, and A. Hirvonen Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism Mutat. Res. 544 2003 9 41
80. S. Singh NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphism imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells J. Steroid Biochem. Mol. Biol. 117 2009 56 66
81. E.L. Cavalieri Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors Chem. Res. Toxicol. 14 2001 1041 1050
82. E.L. Cavalieri Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer Carcinogenesis 23 2002 329 333
83. P. Devanesan Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor alpha knock out (ERKO)/Wnt 1 mice; implications for initiation of mammary tumors Carcinogenesis 22 2001 1573 1576
84. E.G. Rogan Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer Carcinogenesis 24 2003 697 702
85. S. Singh Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma Oncol. Rep. 14 2005 1091 1096
86. N.W. Gaikwad The molecular etiology of breast cancer: evidence from biomarkers of risk Int. J. Cancer 122 2008 1949 1957
87. N.W. Gaikwad Urine biomarkers of risk in the molecular etiology of breast cancer Breast Cancer: Basic Clin. Res. 3 2009 1 8
88. S. Pruthi Evaluation of serum estrogen-DNA adducts as potential biomarkers breast cancer risk J. Steroid Biochem. Mol. Biol. 132 2012 73 79
89. M. Saeed Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol Int. J. Cancer 120 2007 1821 1824
90. M. Zahid Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation Free Radic. Biol. Med. 43 2007 1534 1540
91. J. Russo Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells J. Steroid Biochem. Mol. Biol. 87 2003 1 25
92. J. Russo, and I.H. Russo Genotoxicity of steroidal estrogens Trends Endocrinol. Metab. 15 2004 211 214
93. Zhai, Y. et al. (2012) An in vivo-in vitro model of epithelial mesenchymal transition in triple negative breast cancer. Drug Discov. Today: Dis. Mech. http://dx.doi.org/10.1016/j.ddmec.2012.11.002
94. M.H. Lareef The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells Int. J. Oncol. 26 2005 423 429
95. J. Russo 17β-Estradiol induces transformations and tumorigenesis in human breast epithelial cells FASEB J. 20 2006 1622 1634
96. J.J. Li Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney Cancer Res. 43 1983 5200 5204
97. W.P. Bocchinfuso, and K.S. Korach Mammary gland development and tumorigenesis in estrogen receptor knockout mice J. Mammary Gland Biol. Neoplasia 2 1997 323 334
98. W.P. Bocchinfuso A mouse mammary tumor virus-wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-a Cancer Res. 59 1999 1869 1876
99. W. Yue Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis J. Steroid Biochem. Mol. Biol. 86 2003 477 486
100. R.J. Santen Estradiol-induced carcinogenesis via formation of genotoxic metabolites J.N. Ingle, M. Dowsett, Advances in Endocrine Therapy of Breast Cancer 2003 Marcel Dekker 163 177
101. R. Santen Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects Ann. N. Y. Acad. Sci. 1155 2009 132 140
102. M.M. Montano Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis Oncogene 26 2007 3587 3590
103. M. Zahid Inhibition of depurinating estrogen-DNA adducts formation by natural compounds Chem. Res. Toxicol. 20 2007 1947 1953
104. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
105. M.H. Aziz Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review) Int. J. Oncol. 23 2003 17 28
106. S. De Flora Mechanisms of anticarcinogenesis: the example of N-acetylcysteine C. Ioannides, Drugs, Diet and Disease. Mechanistic Approaches to Cancer Vol. 1 1994 Prentice Hall 151 202
107. S. De Flora Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background J. Cell. Biochem. Suppl. 22 1995 33 41
108. D.M. Townsend The importance of glutathione in human disease Biomed. Pharmacother. 57 2003 45 155
109. K. Cao Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione Chem. Res. Toxicol. 118 1998 909 916
110. K. Cao Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase, lactoperoxidase, or rat liver microsomes Chem. Res. Toxicol. 11 1998 917 924
111. A.M. Samuni Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants Proc. Natl. Acad. Sci. U.S.A. 100 2003 5390 5395
112. D. Venugopal Reduction of estrogen-induced transformation of mouse mammary epithelial cell by N-acetylcysteine J. Steroid Biochem. Mol. Biol. 109 2008 22 30
113. M. Zahid N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells Free Radic. Biol. Med. 49 2010 392 400
114. M. Jang Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
115. L.A. Stivala Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol J. Biol. Chem. 276 2001 22586 22594
116. F.P. Guengerich Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies Mutat. Res. 523-524 2003 173 182
117. M. Floreani Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity Life Sci. 7224 2003 2741 2750
118. M. Zahid Prevention of estrogen-DNA adducts in MCF-10F cells by resveratrol Free Radic. Biol. Med. 45 2008 136 145
119. M. Zahid Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells Free Radic. Biol. Med. 50 2011 78 85